Notice2022-26001
Notice of Award of a Single-Source Cooperative Agreement To Fund the World Health Organization (WHO)
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
November 29, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award of approximately $80,000,000, for Year 1 funding to WHO. The award will support WHO's efforts to support national governments with polio eradication, measles and rubella mortality reduction, and other vaccine preventable disease (VPD) control efforts. Funding amounts for years 2-5 will be set at continuation.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 228 (Tuesday, November 29, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 228 (Tuesday, November 29, 2022)]
[Notices]
[Pages 73308-73309]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-26001]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Award of a Single-Source Cooperative Agreement To Fund
the World Health Organization (WHO)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), located
within the Department of Health and Human Services (HHS), announces the
award of approximately $80,000,000, for Year 1 funding to WHO. The
award will support WHO's efforts to support national governments with
polio eradication, measles and rubella mortality reduction, and other
vaccine preventable disease (VPD) control efforts. Funding amounts for
years 2-5 will be set at continuation.
DATES: The period for this award will be July 1, 2023, through June 30,
2028.
FOR FURTHER INFORMATION CONTACT: Karen Clackum, Center for Global
Health, Global Immunization Division, Centers for Disease Control and
Prevention, 1600 Clifton Rd. NE, Bldg. 21, Atlanta, GA, 30329,
Telephone: 770-488-2680, E-Mail: <a href="/cdn-cgi/l/email-protection#3d767e515c5e5648507d5e595e135a524b"><span class="__cf_email__" data-cfemail="703b331c11131b051d301314135e171f06">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The single-source award will support WHO in
strengthening immunization systems; maintaining and strengthening field
and laboratory-based surveillance; ensuring capacities to quickly and
effectively detect and respond to VPD outbreaks; foster immunization
program sustainability; improve immunization program, policies,
guidelines, and practices at country, regional, and global levels; and
ensure sustained political, technical, and financial support for the
Global Polio Eradication Initiative (GPEI), Measles and Rubella
Partnership, and other disease-specific initiatives as well as for the
Immunization Agenda 2030.
WHO is in a unique position to conduct this work, as it is the only
[[Page 73309]]
organization with a worldwide mandate for the control and prevention of
vaccine preventable diseases (VPDs). WHO also has the lead
responsibility among United Nations (UN) organizations for implementing
the World Health Assembly (WHA) resolutions calling for the global
eradication of polio, elimination of rubella, and multiple other
resolutions with targeted VPD goals. Additionally, no other global
partner or agency has the technical expertise and direct access to
implementation of immunization activities in such a breadth of
countries.
Summary of the Award
Recipient: World Health Organization (WHO).
Purpose of the Award: The purpose of this award is to support WHO's
efforts to support national governments with polio eradication, measles
and rubella mortality reduction, and other vaccine preventable disease
(VPD) control efforts in line with CDC's Global Immunization Strategic
Framework (GISF).
Amount of Award: The approximate year 1 funding amount will be
$80,000,000 in Federal Fiscal Year (FYY) 2023 funds, subject to the
availability of funds. Funding amounts for years 2-5 will be set at
continuation.
Authority: This program is authorized under Sections 301 (c), 307,
and 317 of the Public Health Service Act (42 U.S.C. 241 (c), 242l, and
247b); and section 104 of the Foreign Assistance Act of 1961 (22 U.S.C.
2151b).
Period of Performance: July 1, 2023 through June 30, 2028.
Dated: November 23, 2022.
Terrance Perry,
Chief Grants Management Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2022-26001 Filed 11-28-22; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on November 29, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.